Chemoinformaics analysis of FURANOEREMOPHIL-1-ONE
| Molecular Weight | 232.323 | nRot | 0 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 16 |
| Exact Molecular Weight | 232.146 | nRing | 3 |
| Solubility: LogS | -3.523 | nHRing | 1 |
| Solubility: LogP | 3.383 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 5 |
| nHA | 2 | APOL | 39.9899 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.687 |
| Synth | 4.234 |
| Natural Product Likeliness | 2.582 |
| NR-PPAR-gamma | 0.113 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.041 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.655 |
| MDCK | 0.0000266 |
| BBB | 0.819 |
| PPB | 0.945261 |
| VDSS | 1.884 |
| FU | 0.0626119 |
| CYP1A2-inh | 0.281 |
| CYP1A2-sub | 0.725 |
| CYP2c19-inh | 0.264 |
| CYP2c19-sub | 0.609 |
| CYP2c9-inh | 0.328 |
| CYP2c9-sub | 0.611 |
| CYP2d6-inh | 0.027 |
| CYP2d6-sub | 0.911 |
| CYP3a4-inh | 0.173 |
| CYP3a4-sub | 0.313 |
| CL | 17.107 |
| T12 | 0.637 |
| hERG | 0.022 |
| Ames | 0.012 |
| ROA | 0.769 |
| SkinSen | 0.103 |
| Carcinogencity | 0.361 |
| EI | 0.014 |
| Respiratory | 0.845 |
| NR-Aromatase | 0.151 |
| Antiviral | Yes |
| Prediction | 0.760374 |